These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Accidental mydriasis from scopolamine patches. Rosen NB J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760 [TBL] [Abstract][Full Text] [Related]
4. The pharmacologic absis for the control of motion sickness by drugs. Brand J Pharmacol Physicians; 1968 Mar; 2(3):1-5. PubMed ID: 4384429 [No Abstract] [Full Text] [Related]
5. Transderm scopolamine efficacy related to time of application prior to the onset of motion. Levy GD; Rapaport MH Aviat Space Environ Med; 1985 Jun; 56(6):591-3. PubMed ID: 4015572 [TBL] [Abstract][Full Text] [Related]
6. Control of simulator sickness in an AH-64 aviator. Kroll JD Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677 [TBL] [Abstract][Full Text] [Related]
7. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736 [TBL] [Abstract][Full Text] [Related]
8. I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market? Mayo Clin Health Lett; 1998 Mar; 16(3):8. PubMed ID: 9516375 [No Abstract] [Full Text] [Related]
9. Transderm Scop patches for prevention of motion sickness. Johnson P; Hansen D; Matarazzo D; Petterson L; Swisher C; Trappolini A N Engl J Med; 1984 Aug; 311(7):468-9. PubMed ID: 6749195 [No Abstract] [Full Text] [Related]
10. Transdermal scopolamine in the prevention of motion sickness at sea. Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021 [TBL] [Abstract][Full Text] [Related]
12. Fixed dilated pupil in the long distance traveller. Dunlop IS Med J Aust; 1995 Jan; 162(1):56. PubMed ID: 7845307 [No Abstract] [Full Text] [Related]
15. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness]. Björk M; Wettergren B Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858 [No Abstract] [Full Text] [Related]
16. [Model of motion sickness in white mice experiments]. Zhabko EP; Lukomskaia NIa Aviakosm Ekolog Med; 1997; 31(6):66-8. PubMed ID: 9483286 [No Abstract] [Full Text] [Related]
17. More on Transderm Scop patches. N Engl J Med; 1984 Nov; 311(21):1377-8. PubMed ID: 6493292 [No Abstract] [Full Text] [Related]
18. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility. Uijtdehaage SH; Stern RM; Koch KL Aviat Space Environ Med; 1993 Jan; 64(1):1-8. PubMed ID: 8424733 [TBL] [Abstract][Full Text] [Related]
19. Transdermal scopolamine for motion sickness. Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000 [No Abstract] [Full Text] [Related]
20. [Effectiveness of the preparation Gavinton in preventing motion sickness]. Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]